Rocklatan Adds Pressure Reduction After MIGS (Minimally Invasive Glaucoma Surgery)
NCT07048886
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
68
Enrollment
OTHER
Sponsor class
Conditions
Primary Open Angle Glaucoma
Interventions
DRUG:
Rocklatan (netarsudil 0.02% and latanoprost 0.005%)
DRUG:
Systane
Sponsor
Center for Sight Las Vegas